Recombinant multi-species Syntaxin 12/STX12 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Syntaxin 12/STX12 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Predicted to enable SNAP receptor activity and SNARE binding activity. Involved in autophagosome assembly; cholesterol efflux; and protein stabilization. Located in several cellular components, including membrane raft; phagocytic vesicle; and phagophore assembly site. Part of SNARE complex. Colocalizes with BLOC-1 complex. [provided by Alliance of Genome Resources, Apr 2022]
The Alternative Names of target: Syntaxin 12, STX12,Syntaxin-12,STX13,STX14

Target products collectionGo to Syntaxin 12/STX12 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1848-Ab-1/ GM-Tg-hg-IP1848-Ab-2 Human Syntaxin 12/STX12 protein Human
GM-Tg-rg-IP1848-Ab-1/ GM-Tg-rg-IP1848-Ab-2 Rat Syntaxin 12/STX12 protein Rat
GM-Tg-mg-IP1848-Ab-1/ GM-Tg-mg-IP1848-Ab-2 Mouse Syntaxin 12/STX12 protein Mouse
GM-Tg-cynog-IP1848-Ab-1/ GM-Tg-cynog-IP1848-Ab-2 Cynomolgus/Rhesus macaque Syntaxin 12/STX12 monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1848-Ab-1/ GM-Tg-felg-IP1848-Ab-2 Feline Syntaxin 12/STX12 protein Feline
GM-Tg-cang-IP1848-Ab-1/ GM-Tg-cang-IP1848-Ab-2 Canine Syntaxin 12/STX12 protein Canine
GM-Tg-bovg-IP1848-Ab-1/ GM-Tg-bovg-IP1848-Ab-2 Bovine Syntaxin 12/STX12 protein Bovine
GM-Tg-equg-IP1848-Ab-1/ GM-Tg-equg-IP1848-Ab-2 Equine Syntaxin 12/STX12 protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1848-Ab-1/ GM-Tg-hg-IP1848-Ab-2; GM-Tg-rg-IP1848-Ab-1/ GM-Tg-rg-IP1848-Ab-2;
GM-Tg-mg-IP1848-Ab-1/ GM-Tg-mg-IP1848-Ab-2; GM-Tg-cynog-IP1848-Ab-1/ GM-Tg-cynog-IP1848-Ab-2;
GM-Tg-felg-IP1848-Ab-1/ GM-Tg-felg-IP1848-Ab-2; GM-Tg-cang-IP1848-Ab-1/ GM-Tg-cang-IP1848-Ab-2;
GM-Tg-bovg-IP1848-Ab-1/ GM-Tg-bovg-IP1848-Ab-2; GM-Tg-equg-IP1848-Ab-1/ GM-Tg-equg-IP1848-Ab-2
Products Name Syntaxin 12/STX12 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Syntaxin 12/STX12
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Syntaxin 12/STX12 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.